Histologic and Immunohistochemical Features Associated with Outcome in Neonatal Necrotizing Enterocolitis
15 May 2013
09 June 2013
12 July 2013 (eFirst)
Introduction The aim of the study was to compare histopathologic and immunohistochemical markers between survivors and nonsurvivors of surgical necrotizing enterocolitis (NEC).
Methods With appropriate ethical approval, archived resection specimens were identified for patients with NEC (Bell Stages II and III) for whom outcome data (survival yes/no) were available. For each specimen, a severely affected part of the bowel and the least affected area, usually the margin, were analyzed. Histologic findings were scored as no necrosis/mucosal necrosis/full-thickness necrosis and immunohistochemistry staining for inflammatory markers vascular cell adhesion protein (VCAM), CD68, CD20, intercellular adhesion molecule (ICAM), human leukocyte antigen (HLA-DR), CD3, Cleaved Caspase-3 (CC3), forkhead box P3 (FOXP3), CD62p, and C4d were performed and scored on a semiquantitative scale (0; no staining to 10, strong extensive staining). All samples were identified by only their study number throughout and the samples were analyzed completely blinded to all clinical information. Data were compared using chi-square test for trend (histologic data) or Mann–Whitney U test.
Results A total of 123 slides from 60 patients (birth weight 1.3 ± 0.1kg, gestational age at birth 29.3 ± 0.6 weeks) were examined. Seventy-four specimens (60%) were from survivors and 49 specimens (40%) were from those who subsequently died. There was no relationship between histologic severity of necrosis (none/mucosal/full thickness) and mortality (p = 0.58). VCAM (adhesion molecule; p = 0.005) and CC3 (a marker of apoptosis, p = 0.008) expression was significantly elevated in nonsurvivors, whereas there were no differences in CD68, CD20, ICAM, HLA-DR, CD3, FOXP3, CD62p, or C4d expression.
Conclusions There is a poor relationship between histologic severity of bowel necrosis and patient survival in infants undergoing bowel resection for NEC. There is statistically increased expression of VCAM reflecting severity of systemic inflammatory response and evidence of increased apoptosis in the form of CC3 expression in those who subsequently die, but no histologic features can predict outcome.
- 1 Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364 (3) 255-264
- 2 Kelleher J, Mallick H, Soltau TD, Harmon CM, Dimmitt RA. Mortality and intestinal failure in surgical necrotizing enterocolitis. J Pediatr Surg 2013; 48 (3) 568-572
- 3 Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2007; 92 (3) F193-F198
- 4 Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990; 117 (1 Pt 2) S6-S13
- 5 Schaart MW, de Bruijn AC, Bouwman DM , et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 2009; 49 (1) 31-41
- 6 Sonntag J, Wagner MH, Waldschmidt J, Wit J, Obladen M. Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infants. J Pediatr Surg 1998; 33 (3) 481-484
- 7 Pedersen PV, Hansen FH, Halveg AB, Christiansen ED. Necrotising enterocolitis of the newborn—is it gas-gangrene of the bowel?. Lancet 1976; 2 (7988) 715-716
- 8 Joshi VV, Winston YE, Kay S. Neonatal necrotizing enterocolitis. Histologic evidence of healing. Am J Dis Child 1973; 126 (1) 113-116
- 9 Schaart MW, de Bruijn AC, Bouwman DM , et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 2009; 49 (1) 31-41
- 10 Vieten D, Corfield A, Carroll D, Ramani P, Spicer R. Impaired mucosal regeneration in neonatal necrotising enterocolitis. Pediatr Surg Int 2005; 21 (3) 153-160
- 11 Vieten D, Corfield A, Ramani P, Spicer R. Proliferative response in necrotising enterocolitis is insufficient to prevent disease progression. Pediatr Surg Int 2006; 22 (1) 50-56
- 12 Krueger M, Heinzmann A, Nauck M. Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome. Intensive Care Med 2007; 33 (2) 359-363
- 13 Whalen MJ, Doughty LA, Carlos TM, Wisniewski SR, Kochanek PM, Carcillo JA. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med 2000; 28 (7) 2600-2607
- 14 Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock 2007; 28 (4) 384-393
- 15 Jilling T, Lu J, Jackson M, Caplan MS. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004; 55 (4) 622-629
- 16 Zani A, Cananzi M, Fascetti-Leon F , et al. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 2013; ; [Epub ahead of print]
- 17 Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32 (2) 275-282
- 18 Wu RQ, Dong WF, Wang ZM, Jacob A, Cui T, Wang P. Enhancing apoptotic cell clearance mitigates bacterial translocation and promotes tissue repair after gut ischemia-reperfusion injury. Int J Mol Med 2012; 30 (3) 593-598
- 19 Stefanutti G, Lister P, Smith VV , et al. P-selectin expression, neutrophil infiltration, and histologic injury in neonates with necrotizing enterocolitis. J Pediatr Surg 2005; 40 (6) 942-947 , discussion 947–948
- 20 Parra-Herran CE, Pelaez L, Sola JE, Urbiztondo AK, Rodriguez MM. Intestinal candidiasis: an uncommon cause of necrotizing enterocolitis (NEC) in neonates. Fetal Pediatr Pathol 2010; 29 (3) 172-180